This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Xanthomatosis, Cerebrotendinous
Information about Xanthomatosis, Cerebrotendinous: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Xanthomatosis, Cerebrotendinous
Most recent studies have shown that Xanthomatosis, Cerebrotendinous shares some biological mechanisms with ataxia, atherosclerosis, atrophy, brain-diseases, brain-diseases-metabolic, cataract, cerebellar-ataxia, dementia, diarrhea, inborn-errors-of-metabolism, lipoidosis, myopathy, nervous-system-disorder, nervousness, peripheral-neuropathy, storage-disease, xanthoma, xanthomatosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Xanthomatosis, Cerebrotendinous, and have been seen in publications frequently: Cell Death, Cholesterol Efflux, Cholesterol Esterification, Cholesterol Homeostasis, Cholesterol Transport, Conjugation, Excretion, Lipid Storage, Mrna Splicing, Pathogenesis, Regeneration, Regulation Of Gene Expression, Reverse Cholesterol Transport, Reverse Transcription, Schwann Cell Proliferation, Secretion, Sterol Esterification, Translation, Transport, Urea Cycle
Quite a number of genes have been found to play important roles in Xanthomatosis, Cerebrotendinous, such as ABCB11, ACAT1, ALB, CSF2, CYP27A1, CYP39A1, CYP3A4, CYP7A1, CYP7B1, GUSB, HMGCR, HSD3B1, HSD3B2, LAMC2, NR1H4, NR1I2, QPCT, SLC25A5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.